Ginkgo Bioworks Holdings, Inc. financial data

Symbol
DNA on NYSE, DNABW on OTC
Location
Boston, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 488% % -8%
Operating Margin -185% % 25%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 58,207,298 shares 7.1%
Entity Public Float $553,000,000 USD -77%
Common Stock, Value, Issued $6,000 USD 20%
Weighted Average Number of Shares Outstanding, Basic 55,457,676 shares 6.9%
Weighted Average Number of Shares Outstanding, Diluted 55,457,676 shares 6.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $170,155,000 USD -25%
Research and Development Expense $243,773,000 USD -43%
General and Administrative Expense $183,290,000 USD -26%
Operating Income (Loss) $315,278,000 USD 44%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $313,600,000 USD 43%
Income Tax Expense (Benefit) $837,000 USD -75%
Net Income (Loss) Attributable to Parent $80,755,000 USD -43%
Earnings Per Share, Basic -5.64 USD/shares 46%
Earnings Per Share, Diluted -5.64 USD/shares 46%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $167,202,000 USD -70%
Marketable Securities, Current $255,418,000 USD
Accounts Receivable, after Allowance for Credit Loss, Current $24,026,000 USD 9.9%
Assets, Current $471,838,000 USD -22%
Property, Plant and Equipment, Net $167,783,000 USD -18%
Operating Lease, Right-of-Use Asset $360,918,000 USD -8.5%
Intangible Assets, Net (Excluding Goodwill) $56,924,000 USD -21%
Goodwill $0 USD -100%
Other Assets, Noncurrent $47,167,000 USD -15%
Assets $1,119,696,000 USD -19%
Accounts Payable, Current $10,566,000 USD -25%
Employee-related Liabilities, Current $4,258,000 USD -57%
Contract with Customer, Liability, Current $18,946,000 USD -32%
Liabilities, Current $95,970,000 USD -11%
Contract with Customer, Liability, Noncurrent $75,182,000 USD -24%
Operating Lease, Liability, Noncurrent $417,078,000 USD -4.9%
Other Liabilities, Noncurrent $22,876,000 USD 38%
Liabilities $611,106,000 USD -7.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,851,000 USD
Retained Earnings (Accumulated Deficit) $6,150,320,000 USD -5.4%
Stockholders' Equity Attributable to Parent $508,590,000 USD -29%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $612,952,000 USD -26%
Liabilities and Equity $1,119,696,000 USD -19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $51,521,000 USD 42%
Net Cash Provided by (Used in) Financing Activities $207,000 USD 76%
Net Cash Provided by (Used in) Investing Activities $198,684,000 USD -1541%
Common Stock, Shares Authorized 15,800,000,000 shares 0%
Common Stock, Shares, Issued 61,680,449 shares 6.7%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $250,338,000 USD -145%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $212,371,000 USD -65%
Deferred Tax Assets, Valuation Allowance $840,060,000 USD 8.8%
Deferred Tax Assets, Gross $936,137,000 USD 6.9%
Operating Lease, Liability $439,865,000 USD -5.9%
Payments to Acquire Property, Plant, and Equipment $7,622,000 USD 14%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $309,106,000 USD 44%
Lessee, Operating Lease, Liability, to be Paid $662,799,000 USD -8.4%
Property, Plant and Equipment, Gross $358,380,000 USD -1.7%
Operating Lease, Liability, Current $22,787,000 USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Two $56,745,000 USD 0.94%
Lessee, Operating Lease, Liability, to be Paid, Year One $56,302,000 USD -8%
Operating Lease, Weighted Average Discount Rate, Percent 0.076 pure 1.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $222,934,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Three $58,498,000 USD 3.2%
Deferred Tax Assets, Operating Loss Carryforwards $459,420,000 USD 38%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $60,271,000 USD 3.1%
Additional Paid in Capital $6,657,053,000 USD 1.6%
Amortization of Intangible Assets $18,700,000 USD 3.9%
Deferred Tax Assets, Net of Valuation Allowance $96,077,000 USD -7.5%
Share-based Payment Arrangement, Expense $81,546,000 USD -27%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%